glp-1 receptor agonists and cardiovascular outcome trials an update Efficacy of GLP‐1 in patients with obesity heart failure with preserved ejection fraction: A systematic review and meta‐analysis of randomised controlled - Talavera - 2025 GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
With a sharp focus on metabolic diseases, the company is poised to lead the booming obesity market
The local Integrated Care Board (ICB) has told us that it is planning to commission a community service where we will be able to refer eligible patient in to
& Wu, G
No acute effects of exogenous glucose-dependent insulinotropic polypeptide on energy intake, appetite, or energy expenditure when added to treatment with a long-acting glucagon-like peptide 1 receptor agonist in men with type 2 diabetes
30249-9/asset/ae163e52-907c-4c99-987f-36b369e8996a/main.assets/gr3.gif)
The anti-inflammatory effects may be both direct and indirect
Mathi SK, Chan Y, Li X, and Wheeler MB
